Fundraising FoxDeck Therapeutics
1 known investors
Find your way into Deck Therapeutics
Sign up to see every warm intro you have to Deck Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Deck Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
DeckTherapeutics is a biotech company developing acute omega-3 therapeutics, with a lead neuroprotectant candidate (THDG3) aimed at hypoxic-ischemic brain injuries such as neonatal hypoxic-ischemic encephalopathy and ischemic stroke. The company seeks partners to advance its omega-3 platform and intellectual property.
Investors · 1
Frequently asked questions
- What does Deck Therapeutics do?
- DeckTherapeutics is a biotech company developing acute omega-3 therapeutics, with a lead neuroprotectant candidate (THDG3) aimed at hypoxic-ischemic brain injuries such as neonatal hypoxic-ischemic encephalopathy and ischemic stroke. The company seeks partners to advance its omega-3 platform and intellectual property.
- Who are Deck Therapeutics's investors?
- Deck Therapeutics's investors include Catalytic Impact Foundation.